[go: up one dir, main page]

ES2063080T3 - Procedimiento para la determinacion de anticuerpos. - Google Patents

Procedimiento para la determinacion de anticuerpos.

Info

Publication number
ES2063080T3
ES2063080T3 ES89112374T ES89112374T ES2063080T3 ES 2063080 T3 ES2063080 T3 ES 2063080T3 ES 89112374 T ES89112374 T ES 89112374T ES 89112374 T ES89112374 T ES 89112374T ES 2063080 T3 ES2063080 T3 ES 2063080T3
Authority
ES
Spain
Prior art keywords
receiver
stationary phase
determination
conjugate
mark
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89112374T
Other languages
English (en)
Inventor
Urban Schmitt
Wolfgang Dr Med Dr In Rudinger
Gertraud Dr Ehrlich-Weinreich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2063080T3 publication Critical patent/ES2063080T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PARA LA DETERMINACION DE ANTICUERPOS SEGUN EL PRINCIPIO DEL INMUNOENSAYO Y A TRAVES DE LA INCUBACION CON TRES RECEPTORES (R1,R2 Y R3), SEPARACION DE LOS COMPLEJOS FORMADOS EN LA SOLUCION A TRAVES DEL ENLACE EN UNA FASE ESTACIONARIA Y MEDICION DE LA MARCA EN UNA DE LAS FASES. EL RECEPTOR (R1) ES UN ANTIGENO AGLUTINANTE ESPECIFICAMENTE CON EL ANTICUERPO A DETERMINAR; EL RECEPTOR (R2) ES UN CONJUGADO DE UN RECEPTOR AGLUTINANTE ESPECIFICO CON (R1) Y CON (S1) SUSTANCIA AGLUTINANTE ESPECIFICA Y DETERMINA LA FORMACION DE UNA FASE ESTACIONARIA Y EL RECEPTOR (R3) ES UN CONJUGADO DE UN RECEPTOR AGLUTINANTE ESPECIFICO CON (R1) Y UNA MARCACION Y LLEVA UNA MARCACION. LA INMOVILIZACION DE LOS COMPLEJOS FORMADOS SE EFECTUAN POR EL ENLACE EN UNA FASE ESTACIONARIA DE COMPONENTES AGLUTINANTES ESPECIFICOS CON (S1).
ES89112374T 1988-07-08 1989-07-06 Procedimiento para la determinacion de anticuerpos. Expired - Lifetime ES2063080T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3823262 1988-07-08
DE3907651A DE3907651A1 (de) 1988-07-08 1989-03-09 Verfahren zur bestimmung von antikoerpern

Publications (1)

Publication Number Publication Date
ES2063080T3 true ES2063080T3 (es) 1995-01-01

Family

ID=25869925

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89112374T Expired - Lifetime ES2063080T3 (es) 1988-07-08 1989-07-06 Procedimiento para la determinacion de anticuerpos.

Country Status (7)

Country Link
EP (1) EP0350037B1 (es)
JP (1) JP2613107B2 (es)
CA (1) CA1335786C (es)
DE (2) DE3907651A1 (es)
DK (1) DK338889A (es)
ES (1) ES2063080T3 (es)
FI (1) FI95417C (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4211108A1 (de) * 1992-04-03 1993-10-07 Boehringer Mannheim Gmbh Viruslösung zum Einsatz bei Immunoassays
EP0629857A3 (en) * 1993-06-16 1996-06-26 Nisshin Flour Milling Co Immunoassay for the quantitative determination of antigens.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5510590A (en) * 1978-05-04 1980-01-25 Wellcome Found Enzyme immunity quantity analysis
GB2084317B (en) * 1980-09-30 1984-01-18 Erba Farmitalia Antigen-linked competitive enzymeimmunoassay
US4661444A (en) * 1984-03-29 1987-04-28 Ortho Diagnostic Systems Inc. Homogeneous immunoassays employing double antibody conjugates comprising anti-idiotype antibody
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
US4772550A (en) * 1986-02-10 1988-09-20 Miles Inc. Heterogeneous specific binding assay employing an aggregatable binding reagent
US4778751A (en) * 1986-05-12 1988-10-18 Diagnostic Products Corporation Method for measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies

Also Published As

Publication number Publication date
JPH0266460A (ja) 1990-03-06
DK338889D0 (da) 1989-07-07
FI893333A0 (fi) 1989-07-07
FI95417B (fi) 1995-10-13
FI893333A (fi) 1990-01-09
DK338889A (da) 1990-01-09
DE3907651A1 (de) 1990-01-11
CA1335786C (en) 1995-06-06
EP0350037A3 (en) 1990-12-27
EP0350037A2 (de) 1990-01-10
EP0350037B1 (de) 1994-03-16
JP2613107B2 (ja) 1997-05-21
DE58907208D1 (de) 1994-04-21
FI95417C (fi) 1996-01-25

Similar Documents

Publication Publication Date Title
KR900006778A (ko) 특이적으로 결합가능한 물질의 측정방법
SE7904386L (sv) Biologisk provmetod med utnyttjande av fast fas
ATE161289T1 (de) Repamycinbestimmung
ATE113723T1 (de) Verfahren zur bestimmung von antikörpern.
PT82517B (pt) Ensaio imunologico em fase solida retardada
ES2171676T3 (es) Inmunoensayos por quimioluminiscencia para la deteccion de anticuerpos.
MY104946A (en) Antigen antibody conjugate.
ATE14630T1 (de) Creatinin-antikoerper.
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
ATE40602T1 (de) Immunchemisches messverfahren.
ES2068222T3 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse especificamente.
ES2078923T3 (es) Inmunoensayo enzimatico para detectar los antigenos y fase solida para su realizacion.
GB1499958A (en) Radioimmunoassay methods for the determination of thyroxine
ES2056154T3 (es) Procedimiento para la determinacion de una sustancia capaz de fijarse especificamente.
ATE210827T1 (de) Synthetischer standard für immunoassays
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
ES2063080T3 (es) Procedimiento para la determinacion de anticuerpos.
ES2133503T3 (es) Dosificacion inmunologica de un antigeno o un hapteno.
DE3379400D1 (en) Acetaminophen analogs, antigens, and antibodies
PT85842A (de) Immunometrisches bestimmungsverfahren
ES2103559T3 (es) Inmunoensayo de dos sitios para un anticuerpo con marcado luminiscente y ligando unido a biotina.
JPS6428560A (en) Immunometric measurement
ES8601479A1 (es) Procedimiento para la deteminacion de un antigeno polivalente
KR900006779A (ko) 항원에 대해 특이적인 종류의 항체 측정 방법 및 이 방법을 실행하기 위한 시약

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 350037

Country of ref document: ES